Sonic hedgehog signaling in spinal cord contributes to morphine-induced hyperalgesia and tolerance through upregulating brain-derived neurotrophic factor expression

• Published in: Journal of pain research Vol. 11; pp. 649 - 659
• Main Authors: Liu, Su, Yao, Jun-Li, Wan, Xin-Xin, Song, Zhi-Jing, Miao, Shuai, Zhao, Ye, Wang, Xiu-Li, Liu, Yue-Peng
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 01-01-2018; Taylor & Francis Ltd; Dove Medical Press
• Subjects: Analgesics; Analysis; Anesthesiology; Antibodies; Brain research; Brain-derived neurotrophic factor; Cancer; Drug dosages; Gene expression; hyperalgesia; Kinases; Laboratory animals; Morphine; Narcotics; Neurons; Original Research; Pain; Response time; RNA; sonic hedgehog; Spinal cord; tolerance; United States > US; China; sonic hedgehog; brain-derived neurotrophic factor; hyperalgesia; spinal cord; tolerance
• ISSN: 1178-7090; 1178-7090
• DOI: 10.2147/JPR.S153544

Preventing opioid-induced hyperalgesia and tolerance continues to be a major clinical challenge, and the underlying mechanisms of hyperalgesia and tolerance remain elusive. Here, we investigated the role of sonic hedgehog (Shh) signaling in opioid-induced hyperalgesia and tolerance.
Shh signaling expression, behavioral changes, and neurochemical alterations induced by morphine were analyzed in male adult CD-1 mice with repeated administration of morphine. To investigate the contribution of Shh to morphine-induced hyperalgesia (MIH) and tolerance, Shh signaling inhibitor cyclopamine and Shh small interfering RNA (siRNA) were used. To explore the mechanisms of Shh signaling in MIH and tolerance, brain-derived neurotrophic factor (BDNF) inhibitor K252 and anti-BDNF antibody were used.
Repeated administration of morphine produced obvious hyperalgesia and tolerance. The behavioral changes were correlated with the upregulation and activation of morphine treatment-induced Shh signaling. Pharmacologic and genetic inhibition of Shh signaling significantly delayed the generation of MIH and tolerance and associated neurochemical changes. Chronic morphine administration also induced upregulation of BDNF. Inhibiting BDNF effectively delayed the generation of MIH and tolerance. The upregulation of BDNF induced by morphine was significantly suppressed by inhibiting Shh signaling. In naïve mice, exogenous activation of Shh signaling caused a rapid increase of BDNF expression, as well as thermal hyperalgesia. Inhibiting BDNF significantly suppressed smoothened agonist-induced hyperalgesia.
These findings suggest that Shh signaling may be a critical mediator for MIH and tolerance by regulating BDNF expression. Inhibiting Shh signaling, especially during the early phase, may effectively delay or suppress MIH and tolerance.